IPaDiC successfully secures funding for the development of an implantable insulin pump
Deventer, July 20th 2018 - IPaDiC, a private company that aims to develop an implantable insulin pump, today announced that it has secured funding for the first phase of development. The funding allows IPaDiC to develop and validate a prototype of the insulin pump, called Dialin. The funding is provided by Swanbridge Capital, Sytske Foundation, Stichting DON and Diabetes Fonds.
Ipadic received a loan from RedMed Tech Discovery Fund I in 2016 to take the first steps in the development of the insulin pump.